<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Headache  v2.0 MeG-CLS-045</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="headache">Headache</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Headache is the most common neurologic complaint occurring alone or as part of other syndromes. Most headaches are benign especially where the neurologic examination is normal. However secondary headaches may occasionally have a serious underlying cause which needs to be investigated.</p>
<p>Migraine and tension-type headache are the more common types of primary headache.</p>
<h3 id="target-users">Target users</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
</ul>
<h3 id="target-area-of-use">Target area of use </h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient department</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h3 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h3>
<p>This guideline covers the diagnoses and treatment of the common types of headache.</p>
<p>Patients without features of a potentially dangerous headache should be managed at the Gate Clinic.</p>
<p>Patients referred to the OPD should be assessed for cause of headache and presence of red flag features. Primary headaches typically do not need any further investigations in the absence of red flags.</p>
<p>Patients with acute migraine attacks need immediate treatment with analgesics and antiemetics. Those with more frequent attacks may benefit from long-term prophylaxis.</p>
<p>Acute tension-type headache can be treated with analgesics. Chronic tension-type headaches may improve with lifestyle changes and amitriptyline.</p>
<p>Consider medication overuse headache in patients with chronic headache and longstanding analgesic use.</p>
<h2 id="limitations">Limitations</h2>
<p>Some patients with secondary headaches will require referral to Sheikh Zayed Eye Care Centre or EFSTH depending on their suspected diagnoses. Triptans and verapamil are not readily available in The Gambia.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<p>Suspect a <em>migraine</em> headache if a patient has episodes of moderate to severe unilateral throbbing headache lasting between 4 hours and 3 days with associated nausea, vomiting, photophobia and/or phonophobia. There may be preceding warning signs (aura) which are typically visual. The patient may be able to identify and avoid triggers such as certain foods, menstruation or lifestyle changes.</p>
<p><em>Tension-type</em> headaches are usually less severe, described as tightness or heaviness on head and mostly generalized. There may associated neck and upper back pain. Features of background anxiety disorder or depression may be present. It may be either episodic or chronic (occurring on more than 15 days in a month).</p>
<p><em>Cluster</em> headaches are unilateral with associated eye pain, excessive tearing, nasal congestion or discharge. They occur mostly in male smokers, occurring frequently over a time period (“cluster”) and are far less common causes of headache.</p>
<h3 id="important-things-to-look-for">Important things to look for</h3>
<p>Symptoms and signs of a potentially dangerous headache include the following:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Worst headache patient has ever had: <em>Call the doctor!</em></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Severe headache with nausea and /or vomiting: <em>Call the doctor!</em></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Limb weakness, slurred speech or facial asymmetry: <em>Call the doctor</em> <em>!</em></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Visual disturbances (blurred vision, aversion to light): <em>Call the doctor!</em></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Recent neck stiffness: <em>Call the doctor!</em></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>New type of headache in a patient (“never had this type before”)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Headache that varies with position</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Persistent morning headache with nausea</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>History of head trauma in the last 3 months</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>New onset of headache in:</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Patient younger than 12 years or older than 50 years</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>HIV or Cancer patient</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Female patient on combined oral contraceptive pills</p>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>Raised blood pressure</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Headache present every day for more than 2 weeks</p>
</div></li>
</ul>
<p>Patients with any of these features should be referred from the Gate clinic to the outpatient clinic.</p>
<h2 id="management-in-gate-clinic">Management in Gate clinic</h2>
<p>Treat all patients not referred to the outpatient clinic with</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>oral paracetamol 1 g 3 – 4 times daily for 3 days or</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>ibuprofen 400 mg 3 times daily after meals for 3 days (if patient has used paracetamol already without relief and there are no peptic ulcer symptoms)</p>
</div></li>
</ul>
<p>Tell the patient to return if they deteriorate or if they are not better after 2 days.</p>
<p>If the headache is present along with symptoms of another underlying illness, manage according to the guidelines for that condition.</p>
<h2 id="management-in-opd">Management in OPD</h2>
<h3 id="adults">Adults</h3>
<p>The first step of management is to determine if the headache is a primary or secondary headache. The history is particularly useful in making this distinction.</p>
<p>If it is a secondary headache, look out for sinister features that may suggest a serious underlying cause.</p>
<p>New onset of headache in a patient under 10 or over 50 suggests a secondary cause. Changes in character of a patient’s usual headache is suspicious.</p>
<p>Neurological examination and fundoscopy are very useful in excluding secondary causes of hypertension and should be done at first visit as well as any time there is a change in character of the headache. Visual acuity tests are usually unhelpful.</p>
<p>Primary headaches typically do not need any further investigations in the absence of red flags.</p>
<p>Patients with a history of opioid use for more than 10 days in a month or other analgesics for more than 15 days in a month are at risk for medication overuse headache. Treatment requires withdrawal of the analgesics, psychological support and review after 2 months to determine and treat the underlying primary headache.</p>
<p><strong>Migraine Headache</strong></p>
<p>Start treatment as early as possible during an attack with</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>ibuprofen 400 – 600 mg up to 4 doses in 24 hours or</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>aspirin 600 – 900 mg (not for children or those with contraindications)</p>
</div></li>
</ul>
<p>Add oral metoclopramide 10 mg (in adults) or oral promethazine 1.1 mg/kg (maximum 25 mg) if significant nausea or vomiting is present</p>
<p>Add omeprazole for gastroprotection in those with history of peptic ulcer disease.</p>
<p>A short acting sedative for a few days</p>
<p>Avoid opioids in acute migraine treatment as they worsen nausea and vomiting.</p>
<p>Patients who use analgesics for migraine two or more times every week will need prophylaxis with:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>First line: beta blocker (propranolol, atenolol or bisoprolol)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Second line: amitriptyline</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Third line: sodium valproate.</p>
</div></li>
</ul>
<p>For emergency treatment of patients with severe headaches or unable to tolerate oral medications:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>IM Diclofenac 75 mg stat</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>IM Chlorpromazine 25 mg or IM Metoclopramide 10 mg stat (adults only. Beware acute dystonic reactions)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Continue with oral therapy</p>
</div></li>
</ul>
<p><strong><br />
</strong></p>
<p><strong>Tension-type Headache</strong></p>
<p>If episodes are two or less per week:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>ibuprofen 400 – 600 mg up to 4 doses in 24 hours or</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>aspirin 600 – 900 mg (not for children or those with contraindications)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Add omeprazole for gastroprotection in those with history of peptic ulcer disease.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Advise to stop drugs once pain is relieved.</p>
</div></li>
</ul>
<p>For more frequent episodes or chronic type:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Do not give NSAIDs (risk of medication overuse headache)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Start amitriptyline 12.5 mg nocte. Titrate dose every 2 weeks until improvement or limiting side-effects occur (up to a maximum of 75 mg nocte).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>After sustained improvement for 4 months, gradually taper off dose.</p>
</div></li>
</ul>
<p>Reassure the patient on the nature of the headache.</p>
<p>Counsel on the need for regular exercise and stress management. Non-depressed patients on amitriptyline may require reassurance that they are not been managed for depression.</p>
<p>Avoid opioids.</p>
<h3 id="children">Children</h3>
<p><strong>Evaluation of headache in children</strong></p>
<p>Head is the most common complaint in children. The prevalence of headache in children before 12 years is similar among boys and girls. After 12 years its prevalence is higher in girls.</p>
<p>Childhood headaches are rarely caused by serious underlying disorders. Most children with headaches have either viral infections or upper respiratory tract infections. However more serious conditions are occasionally diagnosed. Primary headaches and infectious aetiologies are also common. <span data-custom-style="headingendmark"> </span>Migraine is the most frequent acute-episodic headache in childhood.</p>
<p>Evaluation of headache in children begins with a good history and a thorough physical examination.</p>
<p>Ask for the following in the history.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Age at onset (Migraines begin in first decade).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Mode of onset (abrupt or insidious)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Headache patterns, (acute, acute recurrent or chronic)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>How often does the pain occur</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>When does the pain occur</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>What is the headache quality (throbbing/pulsating, dull aching, squeezing, etc.)?</p>
</div></li>
</ul>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Location of the pain.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>What makes the headache worse</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Make makes headache go away.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Any associated symptoms.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Past medical history (sickle cell, coagulopathy, immunodeficiency etc.).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Use of medications</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Family history of headache</p>
</div></li>
</ul>
<p>Important aspects of the physical examination in a child with headache include:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>General appearance</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Vital signs (temperature, Pulse, BP)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Anthropometry (head circumference, weight and height)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Auscultation of the neck for bruit</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Palpation of the head and neck for signs of trauma</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Visual fields and fundoscopy.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Otoscopy</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>A complete neurological examination including the spine.</p>
</div></li>
</ul>
<p>When the physical or especially the neurologic examination is abnormal, secondary headaches must be considered and the examination findings may provide clues to diagnosis.</p>
<p><span data-custom-style="headingendmark"><strong>Investigation of headache in children</strong></span></p>
<p>Decisions regarding neuroimaging in children with headaches should be made on a case-by-case basis (CT vs. MRI)</p>
<p>Children with red flag signs and symptoms should undergo neuroimaging.</p>
<p>Neuroimaging is also indicated for severe headache in a child with an underlying disease that predisposes to intracranial pathology (e.g., immune deficiency, sickle cell disease, neurofibromatosis, history of neoplasm, coagulopathy and hypertension)</p>
<p>Laboratory investigations are rarely helpful in the evaluation of children with headaches. A FBC may be helpful. EEG and toxicology screens are not available.</p>
<p>Children in whom intracranial infection or subarachnoid haemorrhage is suspected should undergo lumbar puncture. At least fundoscopy be performed before LP. The ideal thing is neuroimaging before LP.</p>
<p><strong>The treatment of childhood headache</strong> depends on the underlying aetiology. Some management components of recurrent headache disorders include:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Educating the child and family about the headache</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Avoidance of triggers of headache.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Daily exercise where applicable</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Address co-morbid conditions and sleep problems.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Additional non-pharmacologic treatment include: cognitive behavioural therapy, physical therapy, acupuncture etc.</p>
</div></li>
</ul>
<p>The use of acute medication is a key component of treatment. Mild to moderate attacks may be treated with oral paracetamol 15 mg/kg 3 -4 times per day or ibuprofen 10 mg/kg 3 times per day.</p>
<p>The indications for referral may include the following:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Secondary headache requiring specialist management</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Headache associated with mood disturbance and anxiety</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Uncertain diagnosis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Headache refractory to initial management</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Need for more intensive management.</p>
</div></li>
</ul>
<p><strong><br />
</strong></p>
<p><strong>Diagnoses Not To Miss (Investigate and manage urgently)</strong></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Intracranial tumours: morning headache with nausea or vomiting, focal neurologic deficits, seizures (do CT scan)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Meningitis: fever, neck stiffness (do lumbar puncture)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Subarachnoid haemorrhage (SAH): neck stiffness, worst ever headache (do CT scan ± lumbar puncture)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Giant cell (temporal) arteritis: older patient with scalp tenderness, jaw pain when chewing, firm palpable temporal arteries (Do ESR if suspected; treated with steroids)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Primary angle-closure glaucoma: unilateral painful red eye of sudden onset with blurred vision (refer to the eye hospital urgently)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Idiopathic intracranial hypertension: Usually adolescent or young adult female with bilateral blurred vision, vomiting (Fundoscopy – bilateral papilloedema, refer to the eye hospital)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chronic carbon monoxide poisoning: Blurred vision, fatigue, nausea, vomiting. Ask for history of indoor exposure to wood fires and kerosene stoves. Gas cookers producing yellow/orange flames (instead of blue) also increase this risk. (Counsel on risk and advise to discontinue exposure)</p>
</div></li>
</ul>
<h2 id="references">References</h2>
<p><strong>British Association for the Study of Headache. Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type, Cluster and Medication-Overuse Headache. 3<sup>rd</sup> ed. 2010</strong></p>
<p>Bonthius DJ, Hershey AD.headache in children: Approach to evaluation and general management strategies. Uptodate. April 2020.</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Fatai Akemokwe</th>
<th>Date: 23 June 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 24 July 2018</td>
</tr>
<tr class="even">
<td><strong>Reviewed by:</strong></td>
<td>Name: Bubacarr Susso</td>
<td>Date 14 July 2020</td>
</tr>
<tr class="odd">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="even">
<td>1.0</td>
<td>New document</td>
<td>31 July 2020</td>
</tr>
<tr class="odd">
<td>1.1</td>
<td>Executive summary added</td>
<td>31 July 2020</td>
</tr>
<tr class="even">
<td>2.0</td>
<td>Reviewed and addition of guidance for children</td>
<td>01 November 2022</td>
</tr>
<tr class="odd">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
